Breaking News Instant updates and real-time market news.

CA

CA Technologies

$42.97

-1.05 (-2.39%)

, AVGO

Broadcom

$240.54

-4.03 (-1.65%)

10:45
10/10/18
10/10
10:45
10/10/18
10:45

Senator calls for CFIUS review of Broadcom deal for CA Technologies, Axios says

Senator Rand Paul publicly called for a federal national security review of Broadcom's (AVGO) proposed acquisition of CA Technologies (CA), according to Axios. Sources tell Axios that while neither Broadcom nor CA asked for a review of their transaction by CFIUS, some within the defense and energy communities have been agitating for such a review and Paul's urging may make one more likely. Reference Link

CA

CA Technologies

$42.97

-1.05 (-2.39%)

AVGO

Broadcom

$240.54

-4.03 (-1.65%)

CA CA Technologies
$42.97

-1.05 (-2.39%)

09/07/18
BERN
09/07/18
NO CHANGE
Target $310
BERN
Outperform
Broadcom offers attractive risk-reward at current levels, says Bernstein
Bernstein analyst Stacy Rasgon reiterated an Outperform rating and $310 price target on Broadcom (AVGO) following the company's "strong" Q3 report and a similarly strong outlook for Q4. In a research note to investors, Rasgon says that while the recent volatility following the CA (CA) deal announcement was "painful," they may be on the mend as "there was a lot to like" on the company's conference call, including explaining the strategic rationale behind the deal. The stock remains "incredibly cheap," she adds, offering attractive risk-reward.
09/07/18
CHLM
09/07/18
NO CHANGE
Target $300
CHLM
Buy
Broadcom price target cut to $300 from $330 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss reiterated a Buy rating on Broadcom (AVGO) following the company's quarterly results, telling investors in a research note that he likes the rationale behind the CA (CA) deal as the lines blur between hardware and software. While Stoss likes the risk-reward with Broadcom trading at ~10x his FY19 numbers, the analyst lowered his price target to $300 from $330 as he waits for the company to further execute on the CA deal.
09/17/18
PIPR
09/17/18
NO CHANGE
Target $90
PIPR
Overweight
CyberArk price target raised to $90 from $72 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for CyberArk (CYBR) to $90 and keeps an Overweight rating on the shares. Within the last two months, Beyond Trust, CA (Technologies (CA) and Centrify were all acquired, some of which are already creating near-term disruption, Nowinski tells investors in a research note. The analyst believes CyberArk is well positioned to capitalize on this disruption. He notes the takeovers have already led to some layoffs and will likely require extensive work to merge the code bases of the products with the parent company's broader portfolio.
09/25/18
PIPR
09/25/18
NO CHANGE
Target $293
PIPR
Overweight
Broadcom screens cheap across several valuation metrics, says Piper Jaffray
Piper Jaffray analyst Harsh Kumar says he looked at Broadcom (AVGO) across several valuation metrics and the shares stood out as cheap in all earnings, free cash flow, and dividend valuation methods. The analyst believes the stand-alone company can raise its fiscal 2019 dividend to over $9.60. When including the impact of CA Technologies (CA), Kumar believes the dividend could be over $12.50 in fiscal 2020. Further, he believes Broadcom's fundamentals are healthy. The analyst reiterates an Overweight rating on the shares with a $293 price target.
AVGO Broadcom
$240.54

-4.03 (-1.65%)

09/17/18
09/17/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. LULULEMON UPGRADED TO OUTPERFORM: Wells Fargo analyst Ike Boruchow upgraded Lululemon (LULU) to Outperform from Market Perform, stating that while the brand's current strength is "evident to essentially everyone," his recent meetings with management lead him to believe that its "industry leading" momentum is likely sustainable through the second half of this year and well into 2019. While admitting to being "late to the party," Boruchow said he sees meaningful outperformance and upward revisions being ahead for the athletic apparel company. He raised his price target on Lululemon shares to $200 from $144. In late morning trading, Lululemon shares are higher by 2.3%. NOMURA UPGRADES BROADCOM TO BUY: Nomura Instinet analyst Romit Shah upgraded Broadcom (AVGO) to Buy from Neutral and raised his price target for the shares to $300 from $225. The analyst says the "so many positive takeaways from earnings" have forced him to take a more constructive stance on the shares. GOLDMAN SWAPS CONVICTION BUY ON MASTERCARD, VISA: Goldman Sachs analyst James Schneider added MasterCard (MA) to his firm's Conviction List while maintaining a Buy rating on the shares. The analyst also upped his price target for the stock to $260 from $230. Goldman Sachs analyst James Schneider removed Visa (V) from his firm's Conviction List but maintains a Buy rating on the shares with an unchanged price target of $160. The analyst, who continues to see upside to Street estimates, cites the recent share outperformance for the removal. MORGAN STANLEY INITIATES CONSUMER STAPLES: Morgan Stanley analyst Dara Mohsenian assumed Kraft Heinz (KHC) with an Underweight and $52 price target, as he believes it topline growth will likely trail food peers. In late morning trading, Kraft Heinz shares were down almost 2%. The analyst also assumed coverage of Mondelez (MDLZ), General Mills (GIS), and Kellogg (K) with Equal Weight ratings. KEYBANC SEES CANNABIS AS DRIVER FOR SHOPIFY: KeyBanc analyst Monika Garb said she is a buyer of Shopify (SHOP), as the company has "ample" growth opportunities ahead, and she sees potential upside to her above-consensus estimates. She expects that recreational sales of cannabis in Canada could be a GMV and revenue driver and further benefit Shopify's business momentum. Garb maintained an Overweight rating and $182 price target on the shares.
10/04/18
KEYB
10/04/18
NO CHANGE
KEYB
Carrier survey indicates healthy start for Apple iPhone XS, says KeyBanc
KeyBanc analyst John Vinh says his initial round of carrier survey for the current Apple (AAPL) iPhone XS cycle indicates "solid" sell-through for the iPhone XS/Max as inventories are lean post launch. Demand for the iPhone XS Max has been the strongest, with the majority of stores being sold out, while inventories for the iPhone XS are very healthy, he adds. The analyst also notes that demand for the new models appear to be better compared to the iPhone 8/X launch last year, driven mainly by the adoption of a larger screen at iPhone XS Max. Additionally, Vinh is encouraged with the robust results despite limited promotional activity. His favorite Apple supply chain names are Broadcom (AVGO), Qorvo (QRVO), Skyworks (SWKS), and Synaptics (SYNA).
10/08/18
JPMS
10/08/18
NO CHANGE
JPMS
Broadcom custom chip business with Google could hit $1B, says JPMorgan
JPMorgan analyst Harlan Sur says that while there's been a lot of focus around Broadcom's (AVGO) "strong" mobile position at Apple (AAPL), he wants to remind investors of a diversification driver for the company and the "large opportunities" for its datacenter segment, which he notes is growing at a double-digits year-over-year growth rate. The analyst also believes that Google (GOOG, GOOGL) has also engaged with Broadcom on a number of other custom application-specific integrated circuit chip programs. Broadcom's custom ASIC chip business with Google could go from $50M-$75M in 2017 to $800M- $1B over the next 12-18 months and be as big or bigger than Broadcom's custom ASIC chip business at Apple, Sur tells investors in a research note. The analyst thinks the engagement with Google should help Broadcom's datacenter sub-segment sustain double-digit year-over-year growth over the coming years.

TODAY'S FREE FLY STORIES

VEEV

Veeva

$88.99

-2.77 (-3.02%)

14:35
10/23/18
10/23
14:35
10/23/18
14:35
Options
Veeva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
10/23/18
10/23
14:35
10/23/18
14:35
General news
Fed Board minutes showed showed most Banks supported the September 26 rate hike »

Fed Board minutes showed…

TSLA

Tesla

$292.00

30.97 (11.86%)

14:32
10/23/18
10/23
14:32
10/23/18
14:32
Recommendations
Tesla analyst commentary  »

Tesla's moved up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

TTWO

Take-Two

$118.82

-1.69 (-1.40%)

14:30
10/23/18
10/23
14:30
10/23/18
14:30
Periodicals
'Red Dead Redemption 2' development a difficult experience, Kotaku says »

Take-Two's Rockstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

, HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

14:29
10/23/18
10/23
14:29
10/23/18
14:29
Recommendations
Selecta Biosciences, Horizon Pharma analyst commentary  »

Selecta SEL-212 data…

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

BCS

Barclays

$8.60

0.11 (1.30%)

14:20
10/23/18
10/23
14:20
10/23/18
14:20
Options
8-strike put buyers in Barclays Bank ahead of earnings »

8-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SELB

Selecta Biosciences

$8.93

-4.44 (-33.21%)

14:19
10/23/18
10/23
14:19
10/23/18
14:19
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLG

SL Green Realty

$92.15

0.36 (0.39%)

14:18
10/23/18
10/23
14:18
10/23/18
14:18
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/23/18
10/23
14:17
10/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$133.39

-7.945 (-5.62%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Recommendations
Centene analyst commentary  »

Centene should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 14

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$22.65

-1.255 (-5.25%)

14:15
10/23/18
10/23
14:15
10/23/18
14:15
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

SBH

Sally Beauty

$17.78

0.28 (1.60%)

14:09
10/23/18
10/23
14:09
10/23/18
14:09
Hot Stocks
Sally Beauty unveils Sally Beauty Rewards »

"Sally Beauty …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$3.10

-0.02 (-0.64%)

14:06
10/23/18
10/23
14:06
10/23/18
14:06
Hot Stocks
iCAD announces new clinical data on the Xoft Electronic Brachytherapy System »

iCAD announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AMD

AMD

$24.73

-0.31 (-1.24%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Hot Stocks
AMD, Oracle collaborate on EPYC processor-based offering »

At Oracle's (ORCL)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

UNH

UnitedHealth

$261.89

-0.26 (-0.10%)

14:05
10/23/18
10/23
14:05
10/23/18
14:05
Options
UnitedHealth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$152.62

-2.19 (-1.41%)

14:03
10/23/18
10/23
14:03
10/23/18
14:03
Hot Stocks
Facebook introduces Messenger 4 »

In a blog posting,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

14:00
10/23/18
10/23
14:00
10/23/18
14:00
General news
Breaking General news story  »

Dallas Federal Reserve…

KR

Kroger

$28.16

0.17 (0.61%)

13:58
10/23/18
10/23
13:58
10/23/18
13:58
Hot Stocks
Kroger hiring 10,000 associates for holiday season »

The Kroger Co. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

EXAS

Exact Sciences

$63.00

0.68 (1.09%)

13:55
10/23/18
10/23
13:55
10/23/18
13:55
Periodicals
Exact Sciences named a core healthcare short at Hedgeye »

Hedgeye named Exact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

EOG

EOG Resources

$110.23

-6.03 (-5.19%)

13:55
10/23/18
10/23
13:55
10/23/18
13:55
Options
EOG Resources put volume heavy and directionally bearish »

Bearish flow noted in EOG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SELB

Selecta Biosciences

$9.06

-4.31 (-32.24%)

, HZNP

Horizon Pharma

$18.52

-0.735 (-3.82%)

13:53
10/23/18
10/23
13:53
10/23/18
13:53
Hot Stocks
Street Fight: Analysts diverge on Selecta Bio's gout drug data read-through »

Shares of Selecta…

SELB

Selecta Biosciences

$9.06

-4.31 (-32.24%)

HZNP

Horizon Pharma

$18.52

-0.735 (-3.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

13:50
10/23/18
10/23
13:50
10/23/18
13:50
General news
Fed's Bostic continues to tout a gradual path of tightening »

Fed's Bostic…

UNP

Union Pacific

$143.76

-3.04 (-2.07%)

13:47
10/23/18
10/23
13:47
10/23/18
13:47
Periodicals
Union Pacific eliminating 475 positions by year end, World-Herald says »

Union Pacific said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

LNG

Cheniere Energy

$61.13

-2.36 (-3.72%)

13:45
10/23/18
10/23
13:45
10/23/18
13:45
Options
Cheniere Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.